Developing models to understand infectious diseases.
Official title: Pre-Clinical Models of Infectious Diseases
Funded at University of Tennessee Health Sci Ctr · NIH-11197702 · Data updated 2026-11-12
This study is all about building models that mimic infectious diseases so researchers can learn how they work and find better treatments, which could help patients like you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00028-0-759302400001-1 |
| Project ID | NIH-11197702 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals at risk of infectious diseases or those with conditions that could be addressed by new medical countermeasures.
✕Less likely to help
Patients with non-infectious diseases or those who do not meet the criteria for the pre-clinical models may not receive any benefit from this research.
What this research studies
This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and effects. By using these models, researchers aim to test potential medical countermeasures and treatments before they are used in humans. Patients may benefit from the insights gained through these models, which could lead to more effective therapies and prevention strategies for infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for infectious diseases.
How similar studies have gone: Other research has shown success in using pre-clinical models to develop effective treatments for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
-
University of Tennessee Health Sci Ctr
Memphis, United States Active
Related research
Other NIH-funded projects on the same topics.
-
EP2 blockers to protect the brain after a stroke
Aims to test brain-permeable EP2 antagonists to reduce damage after ischemic stroke and improve recovery.
-
HIV drugs may also stop a dangerous fungus from growing
A cancer/antifungal researcher is exploring whether HIV medicines can help treat cryptococcal infections in people with HIV/AIDS.
-
Profiling immune cells to find early inflammation clues in kids with obesity and insulin resistance
This project looks at how immune cells in children with obesity may show early inflammatory changes linked to insulin resistance.
-
Targeted inhibitors to block a key enzyme and fight metastatic triple-negative breast cancer
A new drug candidate aimed at a specific enzyme in cancer cells is being developed to stop the spread of metastatic triple-negative breast cancer.
-
New fungal partner targets to curb Aspergillus infection in vulnerable patients
A NIH-funded project is exploring how the fungus Aspergillus fumigatus grows and causes serious infections in people with weakened immune systems, with the aim of finding new ways to stop it.
-
Epigenetic control of aging heart function
A scientist at a university is studying how aging changes heart function and whether a specific gene, KDM6A, influences this process to uncover ways to prevent or treat aging-related heart problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.